Hyderabad's PopVax opens facility to make personalised mRNA cancer vaccines

Hyderabad biotech startup PopVax has unveiled RNA Foundry, a research, development and manufacturing facility built to produce personalised mRNA cancer vaccines tailored to individual patients. It uses the company's fridge-stable lipid nanoparticle formulation and follows global manufacturing practices. PopVax aims to make more than 100 such vaccines in the next 12 months, handling requests case by case.